Prompt Intervention for Aortic Stenosis Cuts Costs, Improves Outcomes
May 22, 2025
Edwards Lifesciences announced new economic and clinical evidence on severe aortic stenosis (AS) presented as a late-breaking clinical trial at EuroPCR 2025, further contributing to